The Dana-Farber Cancer Institute seeks a scientist with experience in cancer biology, cell biology and preclinical characterization of small molecules to lead the biological sciences group at the newly established Center for Therapeutic Discovery. This is a unique opportunity for a PhD-level biologist to be involved in high-impact drug discovery projects in the newly developed Center for Therapeutic Discovery at Dana-Farber Cancer Institute.

In this role, you will establish a group focused on biological characterization of therapeutic targets and associated pathways. The biology group will also play an important role in preclinical characterization of novel small molecules discovered in the Center for Therapeutic Discovery. Your group will work closely with chemistry, biochemistry, and pharmacology groups to best support the development of novel therapeutics. The role further entails responsibility for projects, management of resources and communication with multiple stakeholders. You will interface with the Center leadership and with faculty and staff at the Dana-Farber Cancer Institute. To be successful, we expect you to have strong technical, communication, leadership, and organizational skills.

We offer competitive compensation at the level of Research Scientist Track at the Dana-Farber, commensurate with experience, and opportunities for career advancement and growth, and be a member of a vibrant and inclusive research community.

Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.

• Ph.D. in Cancer Biology, Cellular and Molecular Biology or related fields and ideally 3+ years of experience in either an academic lab or pharma/biotech.

• Expert in cancerization of cellular responses to pathway perturbation by small molecules or genetic inactivation.
• Practical knowledge of multiple assays including RNAseq, ChIPseq, protein methods and ideally preclinical assessment of novel therapeutic approaches.
• Strong management skills – effectively manages the performance of the team, and their development, to maximize team impact.
• Drives change, challenges dogma, thrives in ambiguous situations.
• Collaborative mindset – capable of working with all stakeholders and project teams to ensure portfolio progress.
• Excellent presentation skills.

At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are equally committed to diversifying our faculty and staff. Cancer knows no boundaries and when it comes to hiring the most dedicated and diverse professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.

Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.